Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin

Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin

Most of the medicines used to treat the novel coronavirus infection (COVID-19) are either approved under an accelerated procedure or not approved for the indication. Consequently, their safety requires special attention.The aim of the study was to review methodological approaches to collecting data...

Full description

Bibliographic Details
Main Authors: Yu. M. Gomon, A. R. Kasimova, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov, S. O. Mazurenko
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-10-01
Series:Безопасность и риск фармакотерапии
Subjects:
pharmacovigilance
adverse drug reactions
spontaneous reports
azithromycin
novel coronavirus infection
covid-19
database
social networks
patient community
Online Access:https://www.risksafety.ru/jour/article/view/281

Similar Items

Similar Items